ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

516 results

Summary and take home messages of the late-breaking clinical trials presented during #TCTConnect 2020

19 Oct 2020

Vijay Kunadian provides a summary of the coronary & structural late-breaking studies presented during TCT Connect 2020 and shares some take-home messages. See how these studies might influence your daily practice!

Vijay Kunadian

Author

Vijay Kunadian
 #TCTConnect 2020 summary and take home messages

PCRonline @ TCT Connect 2020

25 Sep 2020

View reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 online edition of TCT Connect. Check out the list here!

PCR @ TCT 2020

Cisplatin-induced coronary artery thrombosis presented as acute coronary syndrome

16 Sep 2020

Consult this case of a 38-year-old male who presented in the ER with acute chest pain after he had received first cycle of chemotherapy with cisplatin, bleomycin and etoposide for gestational cell tumour with mesenteric mass. The angiogram showed grade IV thrombus in proximal LAD...

Author

Sourabh Agstam
CISPLATIN induced coronary artery thrombosis presented as ACS

Clinical outcomes of calcified nodules detected by optical coherence tomography: a sub-analysis of the CLIMA study

10 Sep 2020

The goal of the present post hoc analysis of the CLIMA registry was to establish the relationship between calcified nodules (CNs) with (CND) or without (CNWD) disruption of the superficial intimal fibrous layer and one-year occurrence of target lesion myocardial infarction (MI) and/or cardiac death.

Authors :

F. Prati, L. Gatto, F. Fabbiocchi, R. Vergallo, G. Paoletti, G. Ruscica, V. Marco, E. Romagnoli, A. Boi, M. Fineschi, G. Calligaris, C. Tamburino, F. Crea, Y. Ozaki, F. Alfonso, E. Arbustini
EuroIntervention - Clinical outcomes of calcified nodules detected by optical coherence tomography: a sub-analysis of the CLIMA study

REALITY - A trial of transfusion strategies for myocardial infarction and anemia

03 Sep 2020

ESC Congress 2020: Tabassome Simon (Paris, France) discusses with Francesco Costa the results of REALITY trial which supports the use of a restrictive strategy for blood transfusion in MI patients with anemia.

Francesco Costa

Author

Francesco Costa
REALITY - A trial of transfusion strategies for myocardial infarction and anemia

When medical history can guide therapeutic choices: an uncommon case of STEMI

26 Aug 2020

In this unusual STEMI case of a 75 year old hypertensive woman, find out how medical history can guide the therapeutic choices and how the interventional cardiologist can resist stent implantation...

Author

Giovanni Valenti
When the medical history can guide the therapeutic choices: an uncommon case of STEMI

MIRTOS trial: Ticagrelor versus Clopidogrel in patients with STEMI treated with thrombolysis

07 Aug 2020

The MIRTOS trial, which included STEMI patients receiving DAPT and thrombolysis ‘together’, aimed to evaluate whether ticagrelor could improve microvascular perfusion and reduce MACE compared to clopidogrel

Reviewer

Ali Nazmi Calik
Can Yucel Karabay

Reviewer

Can Yücel Karabay
MIRTOS trial: Ticagrelor versus Clopidogrel in patients with STEMI treated with thrombolysis

Cangrelor, Tirofiban and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial

15 Jul 2020

The results of the FABOLUS FASTER trial clearly highlight that a high residual platelet reactivity persists when targeting platelet activation by inhibition of the P2Y12 receptor either with Prasugrel or Cangrelor, while tackling the mechanism of platelet adhesion thought the inhibition of GPIIB/IIIA might almost completely...

Luigi Biasco

Reviewer

Luigi Biasco
Primary Results of the FABOLUS FASTER Trial

PCRonline @ ESC Congress 2020: the digital experience

25 Aug 2020

Make sure you stay up to date with what's new and hot in interventional cardiology.

PCR @ ESC Congress 2020: the Digital experience

PCR Trials: Ticagrelor versus Clopidogrel in ACS and invasive management (TICAKOREA)

24 Jul 2020

The objective of this study is to compare the safety and efficacy of ticagrelor with clopidogrel in patients with ACS.

Authors :

Park et al. Circulation. 2019;140:1865-77
PCR Trials: Ticagrelor versus Clopidogrel in ACS and invasive management (TICAKOREA)